News & Insights

  • Clear

Pharmacy Benefit Manager Agrees to Pay $15.2 Million to Settle Allegations of Arkansas Medicaid Overbilling

Arkansas AG Leslie Rutledge reached a settlement with Pharmacy Benefit Manager (“PBM”) Envolve Pharmacy Solutions (“Envolve”), its parent company Centene Corporation, and other Centene subsidiaries (collectively “Centene”) to resolve allegations that Centene used its subsidiaries to overcharge the state for medications in its Medicaid program.

Read More

Drug Distributors and Major Pharmaceutical Company Reach $26 Billion Global Settlement with States to End Opioid Litigation

A bipartisan group of AGs reached a $26 billion global settlement with three major drug distributors and Johnson & Johnson (“J&J”) (collectively “Companies”), pending approval by the vast majority of states and municipalities, to release the Companies from all civil liability relating to the opioid crisis.

Read More

Appeals Court Urged to Let North Dakota’s Laws Regulating Pharmacy Benefit Managers Stand

A bipartisan group of 34 AGs, led by Minnesota AG Keith Ellison, filed an amicus brief in the U.S. Court of Appeals for the Eighth Circuit in support of North Dakota’s position in Pharmaceutical Care Management Association (“PMCA”) v. Wehbi, where North Dakota argued that states have the right to regulate pharmacy benefit managers (“PBMs”) and…

Read More

J&J Settles Opioid-Related New York Suit for $230 Million

New York AG Letitia James reached a settlement with Johnson & Johnson (“J&J”) to resolve allegations that J&J’s activities relating to its manufacture and distribution of opioids caused public nuisance, amounted to common-law fraud, and violated the New York Controlled Substance Act and New York’s consumer protection and finance laws.

Read More

Teva Settles Mississippi Allegations of Price-Fixing Collusion in the Generic Drugs Market

Mississippi AG Lynn Finch reached a settlement with Teva Pharmaceuticals USA, Inc. (“Teva”) to resolve allegations of price fixing and market allocation for numerous generic drugs in violation of the Sherman Act. The settlement stems from a 2019 complaint by 43 state AGs, and the Puerto Rico AG, against Teva and more than a dozen…

Read More